Cryopreservation of freshly isolated porcine islet cells. 2007

P Stiegler, and V Stadlbauer, and S Schaffellner, and H Florian, and C Lackner, and F Iberer, and K Tscheliessnigg
Department for Transplantation Surgery, University Clinic for Surgery, Auenbruggerplatz 29, 8036 Graz, Austria. philipp.stiegler@klinikum-graz.at

BACKGROUND The use of xenogenic islet cells may be a possibility to overcome the shortage of human donor organs to treat diabetes. Microencapsulation seems to be a promising method for immunoprotection. Since isolation, purification, encapsulation, and transplantation of islet cells are labor intensive, cryopreservation has emerged as an attractive system of islet banking. The aim of this study was to determine the influence of three different freezing media (FM) on viability of freshly isolated porcine islet cells (FIPIC). METHODS FIPIC were isolated using a modified Ricordi method and purification performed using a Lymphoprep density gradient. Viability of FIPIC prior to freezing and after thawing was determined using the MTT-based Cell Growth Determination Kit. Insulin production was detected using enzyme-linked immunosorbent assay. Three different FM containing dimethylsulfoxide (DMSO) or glycerol and sucrose were used for cryoprotection of FIPIC. RESULTS Isolation and purification of FIPIC resulted in 95% +/- 1.3% viability and 97% +/- 1.4% purity. Cryopreservation with FM I (containing DMEM, FCS, DMSO) yielded 98.4% and FM III (containing DMEM, FCS, glycerol) 93.1% viability, whereas only 85.6% were alive when cryoprotection is performed with FM II (containing DMSO, BM). Glucose stimulation revealed a loss of 2.8% and 1.9% of insulin secretion per microgram DNA when working with FM I and FM III, but a decrease in glucose-dependent insulin secretion of 7.8% (P < .05) when FIPIC were stored in FM II. CONCLUSIONS Low concentrations of DMSO or the use of glycerol and sucrose seem to be equivalent to cryopreserve FIPIC.

UI MeSH Term Description Entries
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D003451 Cryoprotective Agents Substances that provide protection against the harmful effects of freezing temperatures. Cryoprotective Agent,Cryoprotective Effect,Cryoprotective Effects,Agent, Cryoprotective,Agents, Cryoprotective,Effect, Cryoprotective,Effects, Cryoprotective
D004121 Dimethyl Sulfoxide A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation. DMSO,Dimethyl Sulphoxide,Dimethylsulfoxide,Dimethylsulphinyl,Dimethylsulphoxide,Dimexide,Rheumabene,Rimso,Rimso 100,Rimso-50,Sclerosol,Sulfinylbis(methane),Rimso 50,Rimso50,Sulfoxide, Dimethyl,Sulphoxide, Dimethyl
D005990 Glycerol A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, or sweetening agent. 1,2,3-Propanetriol,Glycerin,1,2,3-Trihydroxypropane,Glycerine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013395 Sucrose A nonreducing disaccharide composed of GLUCOSE and FRUCTOSE linked via their anomeric carbons. It is obtained commercially from SUGARCANE, sugar beet (BETA VULGARIS), and other plants and used extensively as a food and a sweetener. Saccharose
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft

Related Publications

P Stiegler, and V Stadlbauer, and S Schaffellner, and H Florian, and C Lackner, and F Iberer, and K Tscheliessnigg
January 1997, Cell transplantation,
P Stiegler, and V Stadlbauer, and S Schaffellner, and H Florian, and C Lackner, and F Iberer, and K Tscheliessnigg
July 2003, Xenotransplantation,
P Stiegler, and V Stadlbauer, and S Schaffellner, and H Florian, and C Lackner, and F Iberer, and K Tscheliessnigg
May 1984, The Journal of laboratory and clinical medicine,
P Stiegler, and V Stadlbauer, and S Schaffellner, and H Florian, and C Lackner, and F Iberer, and K Tscheliessnigg
December 2011, Journal of endocrinological investigation,
P Stiegler, and V Stadlbauer, and S Schaffellner, and H Florian, and C Lackner, and F Iberer, and K Tscheliessnigg
May 1993, Journal of neuroscience methods,
P Stiegler, and V Stadlbauer, and S Schaffellner, and H Florian, and C Lackner, and F Iberer, and K Tscheliessnigg
January 1981, Transactions - American Society for Artificial Internal Organs,
P Stiegler, and V Stadlbauer, and S Schaffellner, and H Florian, and C Lackner, and F Iberer, and K Tscheliessnigg
January 1990, Hormone and metabolic research. Supplement series,
P Stiegler, and V Stadlbauer, and S Schaffellner, and H Florian, and C Lackner, and F Iberer, and K Tscheliessnigg
January 2003, Cell transplantation,
P Stiegler, and V Stadlbauer, and S Schaffellner, and H Florian, and C Lackner, and F Iberer, and K Tscheliessnigg
June 1999, Annals of the New York Academy of Sciences,
P Stiegler, and V Stadlbauer, and S Schaffellner, and H Florian, and C Lackner, and F Iberer, and K Tscheliessnigg
September 1999, Steroids,
Copied contents to your clipboard!